XENE Xenon Pharmaceuticals Inc.

8-K Current Report

Filed: March 13, 2026

Health Care

Pharmaceutical Preparations

Xenon Pharmaceuticals Inc. (XENE) 8-K current report filed with SEC EDGAR on March 13, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 8.01: Other Events

AI Filing Analysis
8-K

Item 8.01 · Other Events

• Annual meeting details filed with Canadian SEDAR system on March 13, 2026
• Disclosure reflects dual-reporting obligations as a Canadian-incorporated, Nasdaq-listed company

+1 more insights

Other Xenon Pharmaceuticals Inc. 8-K Filings

Get deeper insights on Xenon Pharmaceuticals Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.